查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600986

顱內動脈瘤市場：按類型、適應症和最終用戶分類 - 全球預測 2025-2030

Intracranial Aneurysm Market by Type (Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters), Indication (Ruptured Aneurysm, Unruptured Aneurysm), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年顱內動脈瘤市值為13.2億美元，預計2024年將達16億美元，複合年成長率為22.16%，到2030年將達到53.8億美元。

顱內動脈瘤是指大腦動脈異常擴張，由於潛在的破裂而造成嚴重的健康風險，導致出血性中風等嚴重併發症。高血壓、吸煙和酒精成癮等生活方式相關因素的增加推動了對先進診斷和治療解決方案的需求。由於神經影像學和微創手術技術的創新，顱內動脈瘤市場正在擴大。主要應用在醫療保健領域，特別是神經診斷中心和醫院，重點是血管內卷取和血流轉向支架。從最終用途的角度來看，主要相關人員是醫療保健提供者、研究機構和設備製造商。新興國家的技術進步、醫療保健支出的增加以及醫療保健服務範圍的擴大對市場成長產生了重大影響。此外，世界人口老化以及血管疾病的高盛行率也帶來了進一步成長的潛力。然而，治療成本上升、監管核准嚴格以及低度開發地區認知度低等挑戰可能會阻礙市場擴張。為了抓住新的機遇，公司必須投資研發，以開發具有成本效益和高效的治療方法，並與醫療機構合作進行臨床試驗和教育舉措。最新的機會在於人工智慧主導的診斷工具和患者特定治療計劃的興起，這些可以增強精準醫療。然而，低收入地區的經濟限制和高昂的發展成本仍然是主要障礙。創新研究領域包括生物分解性支架的開發、用於早期檢測的增強生物資訊學以及混合成像技術。市場主要由技術進步和策略聯盟驅動，因此需要積極主動的策略聯盟和持續創新，以應對不斷變化的市場動態和患者需求。

主要市場統計
基準年[2023] 13.2億美元
預測年份 [2024] 16億美元
預測年份 [2030] 53.8億美元
複合年成長率（%） 22.16%

市場動態：快速發展的顱內動脈瘤市場的關鍵市場洞察

供需的動態交互作用正在改變顱內動脈瘤市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於生活方式的改變，腦血管疾病的盛行率增加
    • 傾向微創手術
    • 改善顱內動脈瘤的診斷
  • 市場限制因素
    • 與治療相關的副作用和治療費用上漲
  • 市場機會
    • 活性化研發活動並推出創新技術產品
    • 增加血管內卷取的可能性
  • 市場挑戰
    • 有關手術時機和麻醉誘導的問題

波特五力：駕馭顱內動脈瘤市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解顱內動脈瘤市場的外部影響

外部宏觀環境因素在塑造顱內動脈瘤市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解顱內動脈瘤市場的競爭狀況

顱內動脈瘤市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣顱內動脈瘤市場供應商的績效評估

FPNV定位矩陣是評估顱內動脈瘤市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生活型態改變導致腦血管疾病發生率增加
      • 顱內動脈瘤微創治療趨勢
      • 改善顱內動脈瘤的診斷
    • 抑制因素
      • 與治療相關的副作用和治療費用上漲
    • 機會
      • 活性化研發活動並推出創新技術產品
      • 血管內彈簧圈栓塞的潛力不斷增加
    • 任務
      • 有關手術時機和麻醉誘導的問題
  • 市場區隔分析
    • 類型：對微創技術的需求，例如針對較小囊狀動脈瘤的血管內彈簧圈栓塞術
    • 最終用戶：尋求早期篩檢和診斷服務的診所之間的患者流量增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章顱內動脈瘤市場：依類型

  • 動脈閉塞和搭橋
  • 血管內彈簧圈栓塞術
  • 分流器
  • 手術夾閉

第7章顱內動脈瘤市場（按適應症）

  • 動脈瘤破裂
  • 未破裂動脈瘤

第8章顱內動脈瘤市場：依最終用戶分類

  • 診所
  • 醫院

第9章 北美及南美顱內動脈瘤市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區顱內動脈瘤市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲顱內動脈瘤市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Evasc 宣布臨床里程碑並計劃與德國子公司擴大歐洲業務
    • OU研究人員設計設備以改善腦動脈瘤的治療

公司名單

  • Adeor Medical AG
  • Oxford Endovascular Ltd.
  • F. Hoffmann-La Roche AG
  • Mizuho Medical Co,Ltd.
  • Penumbra, Inc.
  • Acandis GmbH
  • Medtronic PLC
  • Abbott Laboratories
  • Integra Lifesciences Holdings Corporation
  • B. Braun Melsungen AG
  • Cardiatis, SA
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Microport Scientific Corporation
  • Evasc Medical Systems Corp
  • Balt Extrusion SA
  • Terumo Corporation
  • Abbvie Inc.
  • Bayer AG
  • Stryker Corporation
  • Merck & Co., Inc.
  • Kaneka Corporation
Product Code: MRR-A339DAEF9EC7

The Intracranial Aneurysm Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 22.16%, to USD 5.38 billion by 2030.

Intracranial aneurysms refer to the abnormal dilation of arteries within the brain, posing a significant health risk due to potential rupture, leading to severe complications like hemorrhagic stroke. The increasing incidence of lifestyle-related factors such as hypertension, smoking, and alcoholism drives the necessity for advanced diagnostic and therapeutic solutions. With innovations in neuroimaging technologies and minimally invasive surgical techniques, the intracranial aneurysm market is expanding. The primary applications are in the healthcare sector, particularly in neurodiagnostic centers and hospitals, focusing on endovascular coiling and flow-diverting stents. From an end-use perspective, healthcare providers, research institutions, and device manufacturers represent key stakeholders. Market growth is significantly influenced by technological advancements, increasing healthcare expenditures, and expanding access to healthcare services in emerging economies. Additionally, the aging global population, which experiences a higher prevalence of vascular disorders, presents further growth potential. However, challenges such as high costs of treatment, stringent regulatory approvals, and limited awareness in underdeveloped regions can impede market expansion. To capture emerging opportunities, companies should invest in R&D to develop cost-effective and efficient treatment modalities and partner with medical institutions for clinical trials and educational initiatives. The latest opportunities lie in the rise of AI-driven diagnostic tools and patient-specific treatment planning, which can enhance precision medicine. Nevertheless, economic constraints in low-income regions and high development costs remain significant hurdles. Innovative areas for research include the development of biodegradable stents, enhanced bioinformatics for early detection, and hybrid imaging techniques. The market is predominantly driven by technological advancements and strategic collaborations, thus necessitating a proactive approach in strategic partnerships and continuous innovation to cater to shifting market dynamics and patient needs.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 5.38 billion
CAGR (%) 22.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Aneurysm Market

The Intracranial Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
    • Inclination for Minimally Invasive Intracranial Aneurysm Procedures
    • Improved Diagnosis for Intracranial Aneurysm
  • Market Restraints
    • Side Effects Associated with Therapies and High Cost of Treatments
  • Market Opportunities
    • Rise in Research and Development Activities and Introduction of Innovative Technology Products
    • Rising Potential for Endovascular Coiling
  • Market Challenges
    • Issues Related to Timing of Surgery and Anesthetic Induction

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Aneurysm Market

A detailed market share analysis in the Intracranial Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Adeor Medical AG, Oxford Endovascular Ltd., F. Hoffmann-La Roche AG, Mizuho Medical Co,Ltd., Penumbra, Inc., Acandis GmbH, Medtronic PLC, Abbott Laboratories, Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, Cardiatis, S.A., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Pfizer Inc., Microport Scientific Corporation, Evasc Medical Systems Corp, Balt Extrusion S.A., Terumo Corporation, Abbvie Inc., Bayer AG, Stryker Corporation, Merck & Co., Inc., and Kaneka Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters, and Surgical Clipping.
  • Based on Indication, market is studied across Ruptured Aneurysm and Unruptured Aneurysm.
  • Based on End User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
      • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
      • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
      • 5.1.3.2. Rising Potential for Endovascular Coiling
    • 5.1.4. Challenges
      • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
    • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Intracranial Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Artery Occlusion & Bypass
  • 6.3. Endovascular Coiling
  • 6.4. Flow Diverters
  • 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

  • 7.1. Introduction
  • 7.2. Ruptured Aneurysm
  • 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
    • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

Companies Mentioned

  • 1. Adeor Medical AG
  • 2. Oxford Endovascular Ltd.
  • 3. F. Hoffmann-La Roche AG
  • 4. Mizuho Medical Co,Ltd.
  • 5. Penumbra, Inc.
  • 6. Acandis GmbH
  • 7. Medtronic PLC
  • 8. Abbott Laboratories
  • 9. Integra Lifesciences Holdings Corporation
  • 10. B. Braun Melsungen AG
  • 11. Cardiatis, S.A.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Bristol-Myers Squibb Company
  • 14. Pfizer Inc.
  • 15. Microport Scientific Corporation
  • 16. Evasc Medical Systems Corp
  • 17. Balt Extrusion S.A.
  • 18. Terumo Corporation
  • 19. Abbvie Inc.
  • 20. Bayer AG
  • 21. Stryker Corporation
  • 22. Merck & Co., Inc.
  • 23. Kaneka Corporation

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023